All that glitters: sorafenib

Intern Med. 2011;50(7):797. doi: 10.2169/internalmedicine.50.4858. Epub 2011 Apr 1.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Comment

MeSH terms

  • Antineoplastic Agents / adverse effects*
  • Benzenesulfonates / adverse effects*
  • Carcinoma, Hepatocellular / drug therapy*
  • Fatal Outcome
  • Humans
  • Liver Neoplasms / drug therapy*
  • Male
  • Middle Aged
  • Niacinamide / analogs & derivatives
  • Phenylurea Compounds
  • Pyridines / adverse effects*
  • Sorafenib
  • Tumor Lysis Syndrome / etiology*

Substances

  • Antineoplastic Agents
  • Benzenesulfonates
  • Phenylurea Compounds
  • Pyridines
  • Niacinamide
  • Sorafenib